Results 1 to 10 of about 35,373 (217)

Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–2025

Human Vaccines & Immunotherapeutics
Yellow fever vaccination remains the most effective strategy for preventing infection in endemic and travel-associated settings, yet rare severe adverse events such as viscerotropic and neurotropic disease continue to raise safety concerns. Adverse event
Guojun Liang, Qiong Liu, Yang Song
doaj   +1 more source

Experimental DNA-Launched Live-Attenuated Vaccines Against Yellow Fever

Эпидемиология и вакцинопрофилактика, 2019
Background DNA-launched vaccine is “manufactured” in vaccinated individuals and does not require traditional vaccine manufacturing facility and technology. Goals.
P. Pushko, А. А. Ishmukhametov, P. P. Bredenbeek, I. S. Lukashevich   +3 more
doaj   +1 more source

Yellow fever cases in Asia: primed for an epidemic

International Journal of Infectious Diseases, 2016
There is currently an emerging outbreak of yellow fever in Angola. Cases in infected travellers have been reported in a number of other African countries, as well as in China, representing the first ever documented cases of yellow fever in Asia. There is
Sean Wasserman, Paul Anantharajah Tambyah, Poh Lian Lim   +2 more
doaj   +1 more source

Vaccines licensed and in clinical trials for the prevention of dengue

Human Vaccines & Immunotherapeutics, 2017
Dengue has become a major global public health threat with almost half of the world's population living in at-risk areas. Vaccination would likely represent an effective strategy for the management of dengue disease in endemic regions, however to date ...
J. Torresi, G. Ebert, M. Pellegrini
doaj   +1 more source

Adverse events Following Immunization with Fractional one-fifth and one-half doses of Yellow Fever Vaccine compared to full dose in children 9–23 months old in Uganda — Preliminary report

International Journal of Infectious Diseases
Background: In 2016, the World Health Organization recommended that a fractional dose of yellow fever vaccine could be used in persons 2 years of age or older in response to an emergency situation that resulted in a global shortage of available yellow ...
Ms Ellon Twinomuhwezi, Dr. Rebecca M Casey, Dr. Conrad Tumwine, Ms Angela Namwanje, Dr. Winfred Nansozi Nakato, Dr. Arthur Brian Sekiziyivu, Mrs Marjorie Sserunga Najjengo, Dr. Irene Lubega, Dr. Immaculate Ampeire, Ms Alexandra Tuttle, Ms Susan Y. Chub Susan Y Chub, Ms Reena H. H Doshi, Dr. Andrew Kambugu, Dr. Jane F Gidudu   +13 more
doaj   +1 more source

Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane Domains

Vaccines
Background/Objectives: Chimpanzee adenoviral-vectored vaccines have proven to be both safe and effective, with a manufacturing and distribution pipeline capable of rapid global supply, as demonstrated during the COVID-19 pandemic.
Marta Ulaszewska, Ji Ma, Susan J. Morris, Sophie M. Jegouic Goodall, Winnie Kerstens, Hendrik Jan Thibaut, Lotte Coelmont, Kai Dallmeier, Sarah C. Gilbert, Barbara Dema   +9 more
doaj   +1 more source

Yellow Fever Vaccine

Emerging Infectious Diseases, 1999
Subhash C. Arya
doaj   +1 more source

Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017–2019

Emerging Infectious Diseases
Yellow fever (YF) mainly causes severe hepatitis; data on pulmonary pathology remain limited. We investigated respiratory tract pathology in 73 fatal YF cases during the 2017–2019 epidemic in São Paulo, Brazil.
Amaro N. Duarte-Neto, Katia C. Dantas, Suzette C. Ferreira, Fernando R. Giugni, Marielton P. Cunha, Shahab Z. Pour, Felipe L. Ledesma, Yeh-Li Ho, Ana C.S. Nastri, Cinthya S.C. Borges, Fernanda A. Rodrigues, Ceila M.S. Malaque, Jaques Sztajnbok, Thais Mauad, Luiz F.F. Silva, Paulo H.N. Saldiva, Marisa Dolhnikoff   +16 more
doaj   +1 more source

Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV. [PDF]

AIDS, 2023
Motta E, Camacho LAB, Cunha M, de Filippis AMB, Lima SMB, Costa M, Pedro L, Cardoso SW, Cortes FH, Giacoia-Gripp CBW, Morata M, Nazer S, Moreira RI, de Oliveira Souza MC, Mendes YS, Souza Azevedo A, Dos Santos Alvez N, Grinsztejn B, Coelho LE.   +18 more
europepmc   +1 more source

Transmission of yellow fever vaccine virus from breast feeding mothers to their infants: reporting of yellow fever virus (YFV) RNA detection in milk specimens [version 4; peer review: 1 approved, 2 approved with reservations]

F1000Research
Background Because of yellow fever’s serious impact on health, vaccination is the principal strategy to control the disease. Administration of the yellow fever vaccine to breastfeeding women should be before they complete 9 months post-delivery, in order
Abdel Rahim M El Hussein, Hassan Madni, Khalid A. Enan, Isam M. Elkidir, Dina N. Abdelrahman, Razan A. Bashir, Tarteel Hassan   +6 more
doaj   +1 more source